September
2004 -
AiMedics is formally granted the HypoMon® Australian patent. Pat No.
2002233052.
September 2004 -
Results to date of the HypoMon® clinical trials were presented to
the Australian Diabetes Society (ADS) in Sydney.
July 2004 -
The ABC News and Current Affairs featured a news article of the HypoMon®,
on the 7-o'clock news. Click
here for further information.
June 2004 -
HypoMon® preliminary results were presented at the 64th Annual American
Diabetes Association (ADA) Conference, Orlando 2004.
May 2004 -
AiMedics commences phase I clinical studies of the HypoMon® at the
Prince of Wales Hospital, Sydney.
March 2004 -
AiMedics' international PCT patent application for the HypoMon® technology
is granted by the Australian and New Zealand patent offices.
November 2003 -
The HypoMon® 'proof-of-concept' prototype units completed for pre-clinical
studies. Click here to view
these prototypes. A preview of HypoMon® second generation prototypes
can be viewed here.
May 2003 -
The HypoMon® prototype was featured in an Australian national daily
newspaper 'The Australian', titled 'Alarm life-saver for diabetics'. For
further information, click
here.
February 2003 -
AiMedics has formed a strategic alliance with an international scientific
collaboration partner, for the development of the HypoMon® device.
Healthcare Technology Limited (HTL), is a UK-based privately-owned, high
technology manufacturing and distribution company, with branch offices
in USA, France, Denmark, Australia and Taiwan. HTL owns CardioSport®
brand of heart rate monitors and licences its technology to Reebok®.
September 2002 -
The miniaturised HypoMon device is featured in UTS's newspaper, titled
'UTS backs pioneering diabetes monitor'. For further information, click
here.The early version of the HypoMon® device was featured in
a cover story of the University of Technology, Sydney's (UTS) bi-monthly
newspaper, titled 'HypoMon sweetens diabetic lives'. For further information,
click
here.
May 2002 -
Professor Hung Nguyen was appointed a Member in the General Division of
the Order of Australia (AM) for his service to engineering through biomedical
technology research and education.
January 2002 -
Recipient of the NSW government's Department of State and Regional Development
BioFirst grant for the development of the HypoMon® device system.
December 2001 -
Recipient of the prestigious Commonwealth government's Biotechnology Innovation
Fund (BIF) grant. In addition, AiMedics has also received NSW government's
biotechnology grant in January 2002.
page: Previous |